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Abstract
Background: Between 10 % to 48 % of patients develop delirium in acute phase of stroke. Delirium determinants
and its association with other neuropsychiatric disturbances in stroke are poorly understood. The wildly accepted
predictive model of post-stroke delirium is still lacking.
Methods/design: This is a prospective, observational, single-center study in patients with acute phase of stroke. We
aim to include 750 patients ≥18 years with acute stroke or transient ischemic attack admitted to the stroke unit
within 48 hours after stroke onset. The goals of the study are: 1) to determine frequency of delirium and subsyndromal
delirium in Polish stroke patients within 7 days after admission to the hospital; 2) to determine factors associated with
incidence, severity and duration of delirium and subsyndromal delirium and to create a predictive model for post-stroke
delirium; 3) to determine the association between delirium and its cognitive, psychiatric, behavioral and functional short
and long-term consequences; 4) to validate scales used for delirium diagnosis in stroke population.
Patients will be screened for delirium on daily basis. The diagnosis of delirium will be based on DSM-V criteria.
Abbreviated version of Confusion Assessment Method and Confusion Assessment Method for the Intensive Care
Unit will be used for delirium and sub-delirium screening. Severity of delirium symptoms will be assessed by Delirium
Rating Scale Revised 98 and Cognitive Test for Delirium. Patients who survive will undergo extensive neuropsychological,
neuropsychiatric and functional assessment 3 and 12 months after the stroke.
Discussion: This study is designed to provide information on clinical manifestation, diagnostic methods and
determinants of delirium spectrum disorders in acute stroke phase and their short and long-term consequences.
Collected information allow us to create a predictive model for post-stroke delirium.
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Background
Delirium occurs in 10 to 48 % of patients in the acute
phase of stroke [1]. Delirious patients have almost 5-times
higher risk of both in hospital and twelve-month mortality
than non-delirious ones [2]. Patients with post-stroke de-
lirium (PSD) are also over three times more likely to be
discharged to long-term care institutions or nursing home
and their hospital stay is on average 9 days longer [2].
Compared to non-delirious stroke patients, delirious pa-
tients have worse functional outcome after the stroke [3,
4] and lower quality of life one-month after hemorrhagic
stroke [5]. Patients who are delirious in the acute phase of
stroke have lower score in Mini Mental State Examination
1, 6 and 12 months after the stroke [6] and increased risk
for dementia two years after the stroke [7].
A number of predisposing factors for delirium in stroke
were identified. The leading factors in stroke include older
age and the presence of infection [3, 8, 9]. Stroke-related
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risk factors include greater stroke severity [3], stroke in
anterior circulation [3, 10] and specific symptoms of
stroke such as aphasia, neglect or hemianopia [4, 8, 11].
The impact of lesion location and stroke type is uncertain
[4, 10–12]. The predisposing role of environmental factors
has not been investigated in stroke, however in non-stroke
acute settings, only the use of restrains was significantly
associated with higher risk of delirium [13].
Delirium as a life threating process requires quick
identification of affected patients. Therefore, simple and
reliable diagnostic methods are needed. New diagnostic
criteria for delirium were proposed in the fifth edition of
Diagnostic and Statistical Manual of Mental Disorders
(DSM-V) [14, 15]. The concordance between commonly
used screening tools and new criteria was not tested in
stroke settings.
Recently, Oldenbeuving et al. conducted an analysis
on 800 patients with ischemic stroke and described a
tool to predict the risk for PSD; the score is based on pa-
tients age, stroke severity, stroke subtype and infection
[12]. This model has a sensitivity of 76 % and specificity
of 81 % for PSD diagnosis. The usefulness and generality
of this model needs verification in other independent
studies since it was derived and validated in two stroke
units in the Netherlands.
Neuropsychiatric syndromes including depression, ap-
athy, anxiety, emotional liability, fatigue and aggression
are common after stroke. Depression occurs more fre-
quently in patients after stroke than in general popula-
tion. The proportion of people with depression ranges
between 29 % [16] and 33 % [17] up to one year after
stroke. Anxiety after stroke also occurs frequently: meta-
analyses from 44 published studies, showed the overall
estimate of anxiety disorders diagnosed by clinical inter-
view was 18 % and was 25 % for anxiety assessed by rat-
ing scale between 1 to 6 month after stroke [18]. Fatigue
15 months after stroke was found in 57 % of patients
[19]. In meta-analysis from 24 studies, apathy was de-
tected in 34.6 % of patients 3 months after stroke [20].
The cause of these syndromes is unknown but their fre-
quent overlap suggests common underlying mechanisms
i.e. fluctuations in neurotransmitters, inflammatory cas-
cade or disrupted functional connectivity in the limbic
system [21]. The association of these neuropsychiatric
syndromes with delirium were not explored.
Post stroke delirium is a multifactorious, life treating
process, still poorly understood. New, prospective stud-
ies are needed to identify patients at risk of PSD for fu-
ture trials of preventive strategies
Methods/design
Study design
PRospective Observational POLIsh Study on Post-Stroke
Delirium (PROPOLIS) is observational, prospective,
single center, hospital-based cohort study conducted in
Department of Neurology, Jagiellonian University Med-
ical College, Krakow, Poland. The frequency of post-
stroke delirium spectrum disorders, risk factors,
diagnostic tools and prognosis in consecutive 750
stroke patients admitted to the hospital within 48 hours
after the stroke onset will be investigated.
The Local Bioethics Committee approved the study
(KBET/63/B/2014).
The Leading National Research Centre funded the
collection of data for the study.
Objectives
The goals of PROPOLIS are: 1) to determine frequency
of delirium and subsyndromal delirium occurring within
7 days after admission to the hospital in Polish stroke
patients; 2) to determine factors associated with inci-
dence, severity and duration of delirium and subsyndro-
mal delirium and to create a predictive model for PSD;
3) to determine the association between delirium and its
cognitive, psychiatric, behavioral and functional short
and long-term consequences; 4) to validate methods
used for delirium diagnosis in stroke population.
Study population
Patients
All consecutive patients ≥18 years with acute stroke or
transient ischemic attack (TIA) admitted to the Stroke
Unit within 48 hours after stroke onset will be eligible to
participate in the study.
In-hospital procedures
Detailed inclusion and exclusion criteria are shown in
Table 1.
All eligible patients will be screened for delirium on
daily basis. Baseline assessment performed during the
first ten days of hospitalization consists of five elements:
1) collection of data about predisposing factors obtained
from patients and their families; 2) daily basis delirium
assessment during the first seven days after admission;
3) cognitive screenings performed between days 1–2
and 7–10 after admission; 4) evaluation of emotional
and behavioral disturbances between 7–10 day of
hospitalization.
Predisposing factors assessment
Data about three groups of potential predisposing fac-
tors will be collected: socio-demographic, medical and
stroke-related. Table 2 shows the details.
The assessment of pre-existing dementia will be con-
ducted within 48 hours of stroke onset using a Polish
translation of the Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE), version validated in
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Polish population [22]. The IQCODE is 26-item ques-
tionnaire, which asks an informant to rate degree of
change over a ten-year period in various aspects of pa-
tient’s memory and other intellectual abilities. It relies
on the reports of informant and obtains historical mater-
ial, allowing an assessment of cognitive decline rather
than current cognitive impairment. The items are rated
on 5-point scale from 1 - much improved to 5 - much
worse [23]. The cut- off score for presence of pre-stroke
dementia will be 3.4 [24]. For anticholinergic burden as-
sessment the scale proposed by Carnahan will be used,
because positive voice shows good correlation with
serum anticholinergic activity [25].
Delirium assessment
Abbreviated version of Confusion Assessment Method
(bCAM) for verbal patients and Intensive Care Units
version (CAM-ICU) will be used for non-verbal patients
[26–28] for delirium screening. Severity of delirium
symptoms will be assessed by Delirium Rating Scale Re-
vised 98 (DRS-R–98) [29] and Cognitive Test for Delir-
ium (CTD) [30]. CTD rates symptoms at the time of
administration, while DRS and DRS-R–98 rates the pre-
ceding 24 hours. Delirium Motor Checklist (DMC)
[31]will be used to assess number of hyper- and hypoac-
tive symptoms. Delirious patients will be divided into
hypo-, hyperactive, mixed and no subtype according to
criteria from Delirium Motor Subtype Scale 4 [32].
Short, structured questionnaire regarding night and day
behavior and cognitive fluctuations will be fulfilled by
ward nurses. The diagnosis of delirium will be made tak-
ing into account clinical observation, information from
structured nurses questionnaire and cognitive tests. We
will use diagnostic criteria for delirium according to
DSM-V [33]. If patients are not able to perform cogni-
tive evaluation, the diagnosis will be based only on ob-
servation, structured nurses questionnaire and DSM-V
criteria for delirium.
Subsyndromal delirium assessment
Subsyndromal delirium will be diagnosed when one or
more new bCAM/CAM-ICU core symptoms, that did
Table 1 Inclusion and exclusion criteria for the study
Inclusion criteria Exclusion criteria
• Age ≥ 18 years • Coma
• Acute stroke or transient
ischemic attack
• Patients with brain tumor
• Admission to the hospital
within 48 hours of symptoms
onset
• Alcohol withdrawal delirium
• Language: Polish • Cerebral venous thrombosis
• Written informed consent
by patient or legal guardian
• Subarachnoid hemorrhage
• Trauma
• Diseases with life expectancy
less that one year e.g. malignancy
• Vasculitis






Medication Anticholinergic Risk Scale [25]
Pre-stroke functional status Modified Ranking Scale [47], Instrumental Activities of Daily Living [48]
Health history Cumulative Illness Rating Scale [49]
Loss of visual acuity, hearing impairment Medical history, presence of glasses, hearing devices
Infections (pneumonia, urinary tract infection) Diagnosis based on criteria from U.S. Centers for Disease Control and
Prevention [50]
Biochemical disturbances sodium <136 or >145 mmol/L, potassium <3.5 or >5.1 mmol/L, glucose
<3.3 or >5.6 mmol/L, urea nitrogen >8,07 mmol/L, creatynine >106 mmol/L
Pre-stroke dementia Informant Questionnaire on Cognitive Decline in the Elderly [23]
Pre-stroke behavioral and emotional disturbances Neuropsychiatric Inventory [37]
Stroke characteristic
Stoke severity National Institutes of Health Stroke Scale [51]
Subtypes of ischemic stroke The Oxford Community Stroke Project classification [52]
Trial of Org 10172 in Acute Stroke Treatment classification [53]
Stroke symptoms (aphasia, neglect, hemianopia) Clinical examination
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not meet CAM/CAM-ICU criteria for delirium and do
not progress to delirium, will be present [34].
Cognitive assessment
The Montreal Cognitive Assessment (MoCA)[35], Frontal
Assessment Battery (FAB) [30] and Cognitive Test for
Delirium [36] will be used to assess cognitive functions.
Emotional and behavioral assessment
We will gather the information from the spouse/care-
giver regarding pre-stroke behavioral functioning on
Neuropsychiatric Inventory [37]. The presence of de-
pressive symptoms will be assessed by Patient Health
Questionnaire (PHQ–9) [38]; apathy by Apathy Evalu-
ation Scale [39]; anxiety by State Trait Anxiety Inventory
[40] and aggression by The Buss-Durke Inventory [41].
Follow up-measures
Patients will undergo neurological, functional, cognitive,
emotional and behavioral assessment 3 and 12 months
after the stroke. The assessment will be done by a neur-
ologist and psychologist who are blind to patient status
at baseline.
Functional status will be assessed by Instrumental Ac-
tivities of Daily Living (IADL) and modified Rankin Scale
(mRS).
Neuropsychological examination will be performed by
a psychologist. The global cognitive functioning will be
assess by MoCA test [30]. On neuropsychological exam-
ination the following cognitive functions will be assessed:
frontal executive functions (category and letter fluency,
subtests from Mattis Dementia Rating Scale (MDRS)
[42], Trail Making Tests part A and B [43], FAB [36]),
orientation (orientation items of MoCA test), attention
and concentration (digit span, subtest of MoCA, Digit
and Letter Cancelation Test [44]), reasoning (calculation,
arithmetic and verbal problem solving), constructional
and visuospatial functions (subtests of MDRS, construc-
tion of MoCA, Rey-Osterrieth Complex Figure Test)
[44], verbal memory (Luria’s Verbal Learning Test [44]),
nonverbal memory (Rey-Osterrieth Complex Figure
Test), language (repetition, naming), gestural praxis
(subtests of MDRS, pantomiming of object use without
objects), gnosis (identification of objects and naming of
objects’ pictures), writing (subtests of MDRS).
Patients with at least 2 points difference between the
initial and follow up examinations (with a higher score
at follow up), will be diagnosed with transient cognitive
impairment [45].
To track the course of emotional and behavioral dis-
turbances we will use the same scales as for baseline as-
sessment; PHQ–9, Apathy Evaluation Scale, State-Trait
Anxiety Inventory and The Buss-Durke Inventory.
If patients are not willing or are not able to attend fol-
low up visit they and/or their care-givers will be inter-
viewed via telephone. Patients if eligible, will undergo
the telephone version of MoCA, the cut off for cognitive
decline diagnosis will be 18 points [46]. The telephone
interview with a care-giver will include functional
evaluation (Rankin Scale, IADL), cognitive functions
evaluation (IQCODE), depression (NPI items for de-
pression) and structured questionnaire regarding recur-
rent stroke, placement in nursing home and mortality.
The cut off score on IQCODE for post-stroke dementia
will be 3.4 [24].
For those patients who are not able to undergo the
telephone interview only the care-giver will be interview
according to the same procedure as described above.
Study plan flow chart is shown in Fig. 1.
Data monitoring body
Collection of the data will be performed by trained
raters: psychologists and neurologists. Initial diagnosis of
delirium will be reassessed by experienced senior neurol-
ogists and neuropsychologist.
Statistical analysis
To identify predisposing factors multivariable logistic re-
gression analyses will be performed for delirium and
subsyndromal delirium separately. Previously published
predisposing factors will be investigated first, afterward
other factors including confounders and analyzing
effect-measure modifications will be investigated. Poten-
tial risk factors will be narrowed along axes using the
following criteria: (1) prevalence of at least 5 % for
discrete variables; (2) relative risk of 1.3 or higher for delir-
ium at discharge in bivariable analyses (or a statistically
significant parameter estimate at P = .10 for continuous
variables) and (3) clinical relevance. To exclude variables
of multicollinearity, pairwise correlations between the po-
tential explanatory variables will be examined. Final inde-
pendent risk factors will be defined with backward
elimination procedure. To evaluate effects of the predic-
tors on delirium severity and delirium length, a multivari-
ate linear regression adjusted for the covariates and its
interactions mentioned above model will be used. The
prognostic ability of the model to predict delirium will be
calculated using the area under the receiver operating
characteristics curve ranging from 0.5 (no discrimination
above chance) to 1.0 (perfect discrimination). To assess
relationship between delirium and cognitive impairment,
psychiatric and behavioral disturbances Student’s t-test,
Mann–Whitney and chi-square tests will be calculated as
appropriate. The significance level will be α =0,05 for two-
sided null hypotheses.
Validity of bCAM for verbal and CAM-ICU for non-
verbal patients will be assessed by calculation of sensitivity
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and specificity compared with the reference standard
(DSM-V criteria), using standard formula with 95 % confi-
dence intervals.
Discussion
Delirium is a serious complication after stroke. PROP-
OLIS aims to investigate the frequency of delirium
spectrum disorders in Polish population, their risk fac-
tors and long- and short-term prognosis. It also aims
to validate delirium screening tools against DSM-V
criteria.
The strong points of our study are 1) relatively large
number of enrolled, unselective stroke patients including
those with both ischemic and hemorrhages stroke, TIA
and patients with dysphasia; 2) daily screening for delir-
ium; 3) standardized evaluation of cognitive and behav-
ioral correlates.
PROPOLIS will have a clearly defined, comprehensive
delirium assessment based on a new diagnostic criteria
DSM-V.
Neuropsychiatric aspects of behavior in patients with
stroke will be studied, in their connection with delirium
and consequences for short- and long-term prognosis.
Delirium is a complex process requiring input from
many levels including identification of the patients at
risk, control modifiable risk factors and introduce
pharmacological and non-pharmacological treatment as
soon as possible.
PROPOLIS is designed to prospectively investigate de-
lirium spectrum disorders in large Polish stroke popula-
tion, in the interest of the future patients. We hope, the
study will allow us to build a neuro-behavioral predictive
model of PSD spectrum disorders.
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